Alnylam Pharmaceuticals, Inc. (ALNY): Price and Financial Metrics
Alnylam Pharmaceuticals, Inc. (ALNY)
Today's Latest Price: $123.02 USD
1.68 (-1.35%)
Updated Nov 23 4:00pm
Add ALNY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ALNY Stock Summary
- With a market capitalization of $14,487,741,770, Alnylam Pharmaceuticals Inc has a greater market value than 87.41% of US stocks.
- ALNY's price/sales ratio is 36.13; that's higher than the P/S ratio of 94.64% of US stocks.
- Revenue growth over the past 12 months for Alnylam Pharmaceuticals Inc comes in at 137.12%, a number that bests 95.9% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Alnylam Pharmaceuticals Inc, a group of peers worth examining would be GNTX, ACAD, MXIM, EXEL, and CERS.
- ALNY's SEC filings can be seen here. And to visit Alnylam Pharmaceuticals Inc's official web site, go to www.alnylam.com.
ALNY Stock Price Chart Interactive Chart >
ALNY Price/Volume Stats
| Current price | $123.02 | 52-week high | $167.33 |
| Prev. close | $124.70 | 52-week low | $84.97 |
| Day low | $120.83 | Volume | 493,614 |
| Day high | $125.50 | Avg. volume | 690,984 |
| 50-day MA | $134.73 | Dividend yield | N/A |
| 200-day MA | $133.32 | Market Cap | 14.29B |
Alnylam Pharmaceuticals, Inc. (ALNY) Company Bio
Alnylam Pharmaceuticals is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company was founded in 2002 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...